The Chinese CoronaVac jab, a key tool in Brazil's fight against COVID-19, is less effective against the Gamma variant first detected in the virus-ravaged South American country, a study said Friday.
Jul 9, 2021
0
12
An international research team led by HKUST has developed a simple but robust blood test from Chinese patient data for early detection and screening of Alzheimer's disease (AD) for the first time, with an accuracy level of ...
Jun 28, 2021
0
17
Acute elevation in certain plasma microRNAs (miRNAs), along with downregulation of the clusterin protein within two days post-injury can act as early diagnostic and prognostic biomarkers for traumatic brain injury, according ...
Jun 21, 2021
0
1
A large, retrospective, multicenter study involving Washington University School of Medicine in St. Louis indicates that convalescent plasma from recovered COVID-19 patients can dramatically improve likelihood of survival ...
Jun 17, 2021
0
15
Scientists have found clues that the world's leading COVID-19 vaccines offer lasting protection that could diminish the need for frequent booster shots, but they caution that more research is needed and that virus mutations ...
Jun 2, 2021
0
12
Researchers at the Francis Crick Institute have identified a protein that helps tumors evade the immune system and, in certain types of cancers, is linked to a poorer chance of survival. The protein could become a target ...
Jun 2, 2021
0
13
The carefully orchestrated dance between the immune system and the viral proteins that induce immunity against COVID-19 may be more complex than previously thought. A new study by investigators at Brigham and Women's Hospital ...
May 26, 2021
0
4
Months after recovering from mild cases of COVID-19, people still have immune cells in their body pumping out antibodies against the virus that causes COVID-19, according to a study from researchers at Washington University ...
May 24, 2021
2
2692
A preclinical study has found multiple myeloma is highly sensitive to a newly developed experimental therapy, according to research published today by Peter Mac scientists.
May 21, 2021
0
41
A randomized double-blind controlled trial of convalescent plasma for adults hospitalized with severe COVID-19 found that mortality at 28 days in the treatment arm was half the rate seen in the control arm (12.6% vs. 24.6%), ...
May 17, 2021
0
4
